Kazi Tasneem is a Preclinical Senior Scientist at Genentech Inc., specializing in antibody drug development with over 3 years of industry experience. She focuses on computational prediction models for drug transport in preclinical settings, overseeing the design/strategy and interpretation of pharmacokinetics/pharmacodynamics studies for antibody/biologics in cancer immunotherapy. She holds a PhD in Chemical Engineering from Vanderbilt University, a Master’s degree in Materials Science and Engineering from the University of Central Florida and a Master’s degree in Environmental Engineering from Carnegie Mellon University.
She completed her Bachelor’s degree in Chemical Engineering from Bangladesh University of Engineering and Technology (BUET). Kazi is an Advisory Council Member of the Engineering Leadership Program at California State University, Chico. She has received prestigious awards, including the Best Abstract Award for biological modeling from the Society of Toxicology and two Best Research Paper Awards from Vanderbilt University and The Minerals, Metals, & Materials Society. She co-owns a US Patent for a novel design of human organ-on-chip. She was one of the Grace Hopper Celebration Student Scholars of Women in Computing at Anita Borg Institute. She was also honored with the Young Researcher award from Bangladesh, enabling her attendance at the 59th Meeting of Nobel Prize Winners in Chemistry.
Throughout her academic and professional career, Kazi has demonstrated leadership and community involvement, including active roles as Graduate Chair/Professional Development Chair in professional societies like the Society of Women Engineers and the Society of Toxicology, earning recognition such as Guiding Star Award at Society of Women Engineers. Kazi served as Speaker/Co-panelists at a webinar “Career in MedTech” organized by Systers Bangladesh, AnitaBorg Institute.
Comments
Post a Comment